Wockhardt Aims For $12m Annual Savings Through US Restructuring

Plus Serum Vaccines Operation And Diabetes Biosimilars Could Bring Firm Back To Profitability

 
• By Chloe Kent

Wockhardt expects to save up to $12m through restructuring its US business, eyeing up a potential return to profitability by 2025.

Concept of reorganization or restructuring with businessmans hands facing a group of messy plastic blocks on his desk
Wockhardt will shutter its Morton Grove site • Source: Shutterstock

More from Strategy

More from Business